MAPT and Alzheimer disease: Circulating amyloid beta (Aβ), tau, phosphorylated tau (p‐tau)181, p‐tau231, p‐tau217, p‐tauS235, ubiquitin, and lysosomal‐associated membrane protein 1–positive EVs distinguished AD samples.